Gene Therapy for Hemophiliacs Promising
BOSTON, Ma-Scientists successfully used a form of gene therapy to help reduce spontaneous bleeding in hemophiliacs. Preliminary findings reported several patients were treated with weakened viruses for the inherited bleeding disease.
This practice was thrust into the media after a Tucson man died in an unrelated gene therapy experiment last year. Scientists have been trying to use gene therapy for the past 20 years, however these are the first positive results from a trial for hemophilia A.
More than 13,500 Americans suffer from the genetic condition that causes abnormal bleeding.
Gene therapy is considered a new branch of medicine. Normal genes are copied and replaced to compensate for malfunctioning genes in a patient.
The patients in the hemophilia experiment had marble-sized clumps of gene-corrected cells inserted into their abdomens. Each clump contained 100-400 million cells each. The six patients, who ranged in age from 20 to 72, experienced different results. Four volunteers were able to decrease the amount of medication they were taking. Two of the patients had fewer episodes of spontaneous bleeding before the therapy.
Doctors say the treatment will need to be improved to achieve higher levels of the clotting factors but this is the first sign of therapeutic benefits for hemophiliacs.
Information from the Boston Globe.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
